167 related articles for article (PubMed ID: 11722687)
1. Is warfarin really underused in patients with atrial fibrillation?
Weisbord SD; Whittle J; Brooks RC
J Gen Intern Med; 2001 Nov; 16(11):743-9. PubMed ID: 11722687
[TBL] [Abstract][Full Text] [Related]
2. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center.
Bradley BC; Perdue KS; Tisdel KA; Gilligan DM
Am J Cardiol; 2000 Mar; 85(5):568-72. PubMed ID: 11078269
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
[TBL] [Abstract][Full Text] [Related]
4. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
5. Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea.
Lee IH; Kim H; Je NK
J Cardiol; 2015 Dec; 66(6):475-81. PubMed ID: 26242197
[TBL] [Abstract][Full Text] [Related]
6. Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records.
Rosenman MB; Baker L; Jing Y; Makenbaeva D; Meissner B; Simon TA; Wiederkehr D; Deitelzweig S
Curr Med Res Opin; 2012 Sep; 28(9):1407-14. PubMed ID: 22746356
[TBL] [Abstract][Full Text] [Related]
7. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
8. Stroke prevention in atrial fibrillation: are we following the guidelines?
Pusser BE; Robertson SL; Robinson MD; Barton C; Dobson LA
N C Med J; 2005; 66(1):9-13. PubMed ID: 15786672
[TBL] [Abstract][Full Text] [Related]
9. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.
Lewis WR; Fonarow GC; LaBresh KA; Cannon CP; Pan W; Super DM; Sorof SA; Schwamm LH
Am J Cardiol; 2009 Jan; 103(2):227-31. PubMed ID: 19121441
[TBL] [Abstract][Full Text] [Related]
10. The use of warfarin in veterans with atrial fibrillation.
Bravata DM; Rosenbeck K; Kancir S; Brass LM
BMC Cardiovasc Disord; 2004 Oct; 4(1):18. PubMed ID: 15498102
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients?
Putnam W; Nicol K; Anderson D; Brownell B; Chiasson M; Burge FI; Flowerdew G; Cox J
Can Fam Physician; 2004 Sep; 50():1244-50. PubMed ID: 15508374
[TBL] [Abstract][Full Text] [Related]
12. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
13. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
15. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
16. Transitions of care in anticoagulation management for patients with atrial fibrillation.
Deitelzweig SB
Hosp Pract (1995); 2012 Oct; 40(4):20-7. PubMed ID: 23299032
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals.
Munschauer FE; Priore RL; Hens M; Castilone A
Stroke; 1997 Jan; 28(1):72-6. PubMed ID: 8996492
[TBL] [Abstract][Full Text] [Related]
18. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
19. Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation.
Johnston JA; Cluxton RJ; Heaton PC; Guo JJ; Moomaw CJ; Eckman MH
Arch Intern Med; 2003 Jul; 163(14):1705-10. PubMed ID: 12885686
[TBL] [Abstract][Full Text] [Related]
20. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review.
Pugh D; Pugh J; Mead GE
Age Ageing; 2011 Nov; 40(6):675-83. PubMed ID: 21821732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
